(Reuters) -A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over ...

A new Trump administration health initiative called Operation Stork Speed aims to improve the safety of infant formula and ...

The stable outlook reflects Moody’s base case expectations that Reckitt’s gross debt/EBITDA leverage will stay at or below 2.5x, and that the company’s competitive position will continue to support ...

A former commissioner of the Food and Drug Administration says it is vital to invest in ensuring infant formula and breast milk banks are inspected rigorously.

Health and Human Services Secretary Robert F. Kennedy Jr. is planning to meet Tuesday with executives of companies that make ...

Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...

MISSOURI: A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their ...

On Thursday, a Missouri judge ordered ABT and Reckitt Benckiser unit Mead Johnson to face another round of trials over allegations that they failed to warn a mother about the risks of their ...

Investing.com -- Shares of Abbott Laboratories (NYSE:ABT) declined 3.2% after a judge ordered a retrial in the Whitfield case, which originally ruled in favor of Abbott and Reckitt’s Mead Johnson. The ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.

Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for ...

In a statement, Mead Johnson parent company Reckitt Benckiser Group also said it would appeal the decision, which was “at complete odds with the law and the facts.” “This is not a finding of ...